Therapy Areas: Hereditary Disorders
23 September 2021 - - US-based clinical-stage messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has completed dosing of 100 subjects for the Phase 1 portion of the ARC...
21 September 2021 - - US-based clinical stage pharmaceutical company Renovion and the not-for-profit COPD Foundation have created a new partnership to accelerate the development of a novel therapy for...
2 August 2021 - - Genetic testing and selection of embryos generated from in vitro fertilization have given rise to the controversial "designer baby" debate. Recently, the use of a new techn...
2 August 2021 - - US-based clinical-stage messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has inked an agreement with Vinbiocare biotechnology Joint Stock Company, a...
29 July 2021 - - US-based Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) will initiate a Phase 3 development program for the new once-daily investigational triple combination of VX-121/tezacaftor/VX-...
29 July 2021 - - US-based clinical-stage messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has received approval from the UK Health Research Authority to initiate a Ph...
Related Headlines